ペプチドリームの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/10/21 | 4,900 | 5,020 | 4,900 | 4,905 | +25 | +0.5% | 363,300 |
2020/10/20 | 4,910 | 4,960 | 4,875 | 4,880 | -60 | -1.2% | 367,100 |
2020/10/19 | 4,990 | 5,010 | 4,875 | 4,940 | -45 | -0.9% | 460,200 |
2020/10/16 | 5,020 | 5,090 | 4,970 | 4,985 | -85 | -1.7% | 274,500 |
2020/10/15 | 5,070 | 5,140 | 5,020 | 5,070 | -40 | -0.8% | 310,800 |
2020/10/14 | 5,070 | 5,180 | 5,060 | 5,110 | +80 | +1.6% | 516,900 |
2020/10/13 | 4,960 | 5,060 | 4,935 | 5,030 | +105 | +2.1% | 369,600 |
2020/10/12 | 4,890 | 4,955 | 4,885 | 4,925 | +35 | +0.7% | 218,400 |
2020/10/09 | 4,900 | 4,940 | 4,860 | 4,890 | +25 | +0.5% | 361,700 |
2020/10/08 | 4,880 | 4,940 | 4,835 | 4,865 | +15 | +0.3% | 329,800 |
2020/10/07 | 4,835 | 4,865 | 4,785 | 4,850 | +20 | +0.4% | 325,300 |
2020/10/06 | 4,800 | 4,925 | 4,780 | 4,830 | +55 | +1.2% | 434,200 |
2020/10/05 | 4,785 | 4,815 | 4,700 | 4,775 | +60 | +1.3% | 349,900 |
2020/10/02 | 4,865 | 4,910 | 4,645 | 4,715 | - | - | 850,800 |
2020/10/01 | 0 | 0 | 0 | 0 | - | - | 0 |
2020/09/30 | 4,950 | 5,160 | 4,905 | 4,920 | +30 | +0.6% | 1,265,300 |
2020/09/29 | 4,700 | 4,905 | 4,675 | 4,890 | +150 | +3.2% | 1,108,400 |
2020/09/28 | 4,515 | 4,740 | 4,510 | 4,740 | +270 | +6% | 963,300 |
2020/09/25 | 4,290 | 4,485 | 4,275 | 4,470 | +165 | +3.8% | 541,600 |
2020/09/24 | 4,300 | 4,375 | 4,270 | 4,305 | -45 | -1% | 402,700 |
2020/09/23 | 4,390 | 4,400 | 4,340 | 4,350 | -55 | -1.2% | 464,200 |
2020/09/18 | 4,390 | 4,410 | 4,355 | 4,405 | +15 | +0.3% | 450,400 |
2020/09/17 | 4,370 | 4,435 | 4,335 | 4,390 | -50 | -1.1% | 522,100 |
2020/09/16 | 4,310 | 4,440 | 4,310 | 4,440 | +140 | +3.3% | 390,600 |
2020/09/15 | 4,345 | 4,350 | 4,275 | 4,300 | -35 | -0.8% | 314,100 |
2020/09/14 | 4,275 | 4,370 | 4,255 | 4,335 | +75 | +1.8% | 320,900 |
2020/09/11 | 4,270 | 4,290 | 4,210 | 4,260 | +10 | +0.2% | 419,000 |
2020/09/10 | 4,245 | 4,275 | 4,230 | 4,250 | +30 | +0.7% | 366,800 |
2020/09/09 | 4,250 | 4,285 | 4,215 | 4,220 | -100 | -2.3% | 742,600 |
2020/09/08 | 4,240 | 4,320 | 4,200 | 4,320 | +85 | +2% | 374,400 |
2020/09/07 | 4,175 | 4,275 | 4,165 | 4,235 | +40 | +1% | 264,000 |
2020/09/04 | 4,150 | 4,225 | 4,150 | 4,195 | -45 | -1.1% | 285,800 |
2020/09/03 | 4,310 | 4,315 | 4,195 | 4,240 | -65 | -1.5% | 490,700 |
2020/09/02 | 4,355 | 4,380 | 4,260 | 4,305 | -45 | -1% | 338,500 |
2020/09/01 | 4,295 | 4,380 | 4,290 | 4,350 | +45 | +1% | 293,800 |
2020/08/31 | 4,305 | 4,405 | 4,285 | 4,305 | +140 | +3.4% | 580,900 |
2020/08/28 | 4,270 | 4,285 | 4,135 | 4,165 | -130 | -3% | 645,700 |
2020/08/27 | 4,350 | 4,385 | 4,280 | 4,295 | -50 | -1.2% | 287,400 |
2020/08/26 | 4,360 | 4,365 | 4,310 | 4,345 | -25 | -0.6% | 284,200 |
2020/08/25 | 4,445 | 4,445 | 4,370 | 4,370 | -50 | -1.1% | 223,800 |
2020/08/24 | 4,330 | 4,420 | 4,290 | 4,420 | +70 | +1.6% | 359,500 |
2020/08/21 | 4,370 | 4,440 | 4,340 | 4,350 | -20 | -0.5% | 446,900 |
2020/08/20 | 4,465 | 4,480 | 4,350 | 4,370 | -160 | -3.5% | 577,000 |
2020/08/19 | 4,530 | 4,565 | 4,495 | 4,530 | -5 | -0.1% | 358,500 |
2020/08/18 | 4,510 | 4,560 | 4,470 | 4,535 | +35 | +0.8% | 403,200 |
2020/08/17 | 4,620 | 4,635 | 4,495 | 4,500 | -190 | -4.1% | 462,500 |
2020/08/14 | 4,620 | 4,730 | 4,605 | 4,690 | +15 | +0.3% | 384,100 |
2020/08/13 | 4,710 | 4,725 | 4,660 | 4,675 | -45 | -1% | 413,400 |
2020/08/12 | 4,600 | 4,735 | 4,570 | 4,720 | +125 | +2.7% | 499,400 |
2020/08/11 | 4,530 | 4,625 | 4,465 | 4,595 | +70 | +1.5% | 577,800 |
1101~
1150
件表示中 / 2899件
類似銘柄と比較する
現在ご覧いただいている「ペプチド」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ペプチド | 187,600円 | +5.0% | +1.5% | 0.00% | 16.10倍 | 4.28倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
日本新薬 | 357,000円 | +7.9% | +8.9% | 3.47% | 7.64倍 | 1.02倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
住友ファーマ | 62,700円 | +21.1% | - | 0.00% | 15.57倍 | 2.18倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
科研薬 | 410,900円 | +30.5% | +111.0% | 4.62% | 11.58倍 | 1.01倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
キッセイ薬 | 378,000円 | +14.5% | -2.3% | 2.38% | 13.83倍 | 0.74倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
市場注目の銘柄
チャート関連のコラム